FRCPath Haem Part 1 MCQ-Oncology 220

A 77-yr-pt man with TP53-mutated CLL has severe atrial fibrillation precluding BTKi use. Which therapy can be offered as ist line to this patient?

• Venetoclax monotherapy
• Venetoclax + Obinutuzumab
• Venetoclax + Ibrutinib
• FCR

See All Options